Improving patient outcomes through better use of blood products
Improving patient outcomes through better use of blood products
批准号:
nhmrc : 1194811
负责人:
金额:
$141.23万
依托单位国家:
澳大利亚
项目类别:
Investigator Grants
财政年份:
2021
资助国家:
澳大利亚
项目状态:
未结题
起止时间:
2021-01-01 至 2025-12-31
中文摘要
如果使用得当,输血可以挽救生命。血液必须明智地使用:它是由志愿者捐献的,给社会带来了风险和巨大的成本。尽管这是一种常见的干预措施,但许多领域的证据不足以就如何使用血液提出建议。这项研究计划将通过进行临床试验来比较输血策略、评估替代输血并测试新的血液成分,从而解决证据薄弱的国家优先事项。
英文摘要
Blood transfusions, used wisely, save lives. Blood must be used judiciously: it is donated by volunteers, and carries risks and great cost to the community. Although a common intervention, evidence in many areas is inadequate to formulate recommendations on how blood should be used. This research program will address national priorities where evidence is weak by undertaking clinical trials to compare transfusion strategies, evaluate alternatives to transfusion and test novel blood components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金